Tumor type | Results | References |
---|---|---|
Bladder cancer | ∆ DANCR: ↓ tumor volume, tumor growth and metastasis | [8] |
∆ DANCR: ↓ tumor weight, and tumor growth | [9] | |
Breast cancer | ∆ DANCR: ↓ tumor growth | [27] |
∆ DANCR: ↓ tumor growth | [29] | |
∆ DANCR: ↓ tumor growth | [35] | |
∆ DANCR: ↓ tumor weight, tumor volume | [36] | |
∆ DANCR: ↓ tumor growth | [37] | |
RGD-PEG-ECO/siDANCR nanoparticles: ↓ proliferation | [38] | |
Cervical cancer | ∆ DANCR: ↓ tumor growth | [40] |
∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth | [41] | |
↑ miR-665 (a target of DANCR): ↓ tumor weight and tumor growth | [42] | |
Cholangiocarcinoma | ∆ DANCR: ↓ tumor growth | [43] |
∆ DANCR: ↓ tumor weight and tumor growth | [44] | |
Colon cancer | ∆ DANCR: ↓ glycolysis rate and ↑ cisplatin sensitivity | [21] |
∆ DANCR: ↓ tumor formation and metastasis | [22] | |
∆ DANCR: ↓ tumor volume, and tumor growth | [45] | |
Colorectal cancer | ↑↑ DANCR: ↑ tumor volume and tumor growth | [49] |
Gastric cancer | ∆ DANCR: ↓ tumor growth | [31] |
∆ DANCR: ↓ tumor weight, tumor volume, tumor size and proliferation | [32] | |
↑↑ DANCR: ↑ cell growth and tumorigenicity | [54] | |
Glioma | ∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth | [55] |
∆ DANCR: ↑ apoptosis-inducing roles of cisplatin in vivo | [58] | |
Hepatocellular carcinoma | ↑↑ DANCR: ↑ sorafenib resistance | [18] |
∆ DANCR: ↓ cell vitality, tumor shrinkage | [19] | |
∆ DANCR: ↓ tumor growth and lung metastasis | [20] | |
∆ DANCR: ↓ tumor growth and lung metastasis | [62] | |
Lung cancer | ∆ DANCR: ↓ tumor growth | [10] |
∆ DANCR: ↓ tumor growth | [12] | |
∆ DANCR: ↓ tumor weight, tumor volume and tumor growth | [65] | |
∆ DANCR: ↓ tumor growth | [66] | |
∆ DANCR: ↓ tumor volume | [67] | |
Nasopharyngeal carcinoma | ∆ DANCR: ↓ tumor size and tumor growth | [71] |
∆ DANCR: ↓ tumor volume and tumor weight | [72] | |
∆ DANCR: ↓ invasion and metastasis | [73] | |
Oral squamous cell carcinoma | ∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth | [75] |
Osteosarcoma | ↑↑ DANCR: ↑ tumor growth and metastasis | [3] |
∆ DANCR: ↓ tumor size and tumor volumes | [2] | |
∆ DANCR: ↓ tumor growth and autophagy | [5] | |
∆ METTL3: ↓ tumor volumes (DANCR could be a target of METTL3) | [6] | |
Ovarian cancer | ∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth | [78] |
Pancreatic cancer | DANCR was up-regulated as pancreatic cancer progressed | [89] |
∆ DANCR: ↓ tumor growth | [25] | |
Prostate cancer | ∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth | [84] |
∆ DANCR: ↓ metastasis | [85] | |
Tongue squamous cell carcinoma | ∆ DANCR: ↓ tumor growth and tumor formation | [88] |